Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1810 Records) |
Query Trace: Immunotherapy[original query] |
---|
Exploration of bacterial lipopolysaccharide-related genes signature based on T cells for predicting prognosis in colorectal cancer. Aging 2024 8 16 . Lichao Cao, Ying Ba, Fang Chen, Shenrui Zhang, Hezi Zha |
Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non-Small Cell Lung Cancer. Cancer research communications 2024 8 . Daniel R Principe, Mary M Pasquinelli, Ryan H Nguyen, Hidayatullah G Munshi, Alicia Hulbert, Alexandre F Aissa, Frank Weinbe |
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer. Cancer immunology, immunotherapy : CII 2024 8 73 (10): 197. Changhee Park, Koung Jin Suh, Se Hyun Kim, Kyung-Hun Lee, Seock-Ah Im, Min Hwan Kim, Joohyuk Sohn, Jae Ho Jeong, Kyung Hae Jung, Kyoung Eun Lee, Yeon Hee Park, Hee-Jun Kim, Eun Kyung Cho, In Sil Choi, Seung-Jae Noh, Inkyung Shin, Dae-Yeon Cho, Jee Hyun K |
Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis. Cancer immunology, immunotherapy : CII 2024 8 73 (10): 193. Guangzhong Guo, Ziyue Zhang, Jiubing Zhang, Dayang Wang, Sensen Xu, Guanzheng Liu, Yushuai Gao, Jie Mei, Zhaoyue Yan, Ruijiao Zhao, Meiyun Wang, Tianxiao Li, Xingyao |
Alterations in genes involved in glycolysis and hypoxia affect the prognosis of pancreatic cancer. Heliyon 2024 8 10 (14): e34104. Yujie Huang, Qilu Zhu, Yizhang Sun, Weigang Zhang, Jiayue Z |
Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study. Nature communications 2024 8 15 (1): 7255. Xiaojing Xu, Luoyan Ai, Keshu Hu, Li Liang, Minzhi Lv, Yan Wang, Yuehong Cui, Wei Li, Qian Li, Shan Yu, Yi Feng, Qing Liu, Ying Yang, Jiao Zhang, Fei Xu, Yiyi Yu, Tianshu L |
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab. JCO precision oncology 2024 8 8 e2400100. Alberto Hernando-Calvo, S Y Cindy Yang, Maria Vila-Casadesús, Ming Han, Zhihui Amy Liu, A Hal K Berman, Anna Spreafico, Albiruni Abdul Razak, Stephanie Lheureux, Aaron R Hansen, Deborah Lo Giacco, Farnoosh Abbas-Aghababazadeh, Judith Matito, Benjamin Haibe-Kains, Trevor J Pugh, Scott V Bratman, Alexey Aleshin, Roger Berche, Omar Saavedra, Elena Garralda, Sawako Elston, Lillian L Siu, Pamela S Ohashi, Ana Vivancos, Philippe L Beda |
Effect of TTF-1 expression on progression free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer. Journal of cancer research and clinical oncology 2024 8 150 (8): 394. Mark Uhlenbruch, Stefan Krüg |
Predictive value and molecular correlates of MYC immunohistochemistry and copy number gain in non-small cell lung carcinomas treated with immunotherapy. Lung cancer (Amsterdam, Netherlands) 2024 8 195 107927. Julia Naso, Aakash Desai, Caleb J Smith, Yash P Ashara, Stephen Yip, Ying-Chun |
Clinical and molecular correlates of tumor aneuploidy in metastatic non-small cell lung cancer. Scientific reports 2024 8 14 (1): 19375. Liam F Spurr, Sean P Pitro |
Chemotherapy and programmed cell death protein 1/programmed death-ligand 1 inhibitor combinations for tyrosine kinase inhibitor-resistant, epidermal growth factor receptor-mutated non-small-cell lung cancer: a meta-analysis. ESMO open 2024 8 9 (9): 103660. Z Piotrowska, B Y Yeap, J F Gain |
Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents. Frontiers in pharmacology 2024 8 15 1391972. Xuanhong Jin, Yang Pan, Cheng Cheng, Hangchen Shen, Chongya Zhai, Kailai Yin, Xinyu Zhu, Hongming Pan, Liangkun Y |
Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancer. Frontiers in molecular biosciences 2024 8 11 1426274. Weiwei Gong, Mingqin Kuang, Hongxi Chen, Yiheng Luo, Keli You, Bin Zhang, Yueyang L |
Pan?cancer analysis on the role of KMT2C expression in tumor progression and immunotherapy. Oncology letters 2024 8 28 (3): 444. Wei Cao, Yawen Xie, Li Cai, Mengqing Wang, Zhuoying Chen, Ziteng Wang, Jiajia Xv, Yuqing Wang, Rong Li, Xuesong Liu, Wenliang Wa |
Pulmonary adenocarcinoma with enteric differentiation (PAED) without TTF-1 expression is a very rare subtype with limited treatment options and poor prognosis. Oncology 2024 8 . Franziska Maria Kraus, Alexander Traut, Georg Nilius, Jan Volmerig, Andreas Koziorowski, Imke Stöver, Florian Grabellus, Michael Stahl, Daniel C Christo |
A novel M2-like tumor associated macrophages-related gene signature for predicting the prognosis and immunotherapy efficacy in gastric cancer. Discover oncology 2024 8 15 (1): 353. Xuezhi Li, Xiaodong Qu, Na Wang, Songbo Li, Xingyu Zhao, Kexin Lin, Yongquan S |
Efficacy of immunotherapy in RET fusion-positive NSCLC: A meta-analysis. Heliyon 2024 8 10 (14): e34626. Zhongsheng Peng, Kaibo Ding, Mingying Xie, Yanjun |
A comprehensive molecular characterization of a claudin-low luminal B breast tumor. Biology direct 2024 8 19 (1): 66. Sara Giovannini, Artem Smirnov, Livia Concetti, Manuel Scimeca, Alessandro Mauriello, Julia Bischof, Valentina Rovella, Gerry Melino, Claudio Oreste Buonomo, Eleonora Candi, Francesca Bernasso |
Identification and validation of tryptophan-related gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma reveals a critical role for PTTG1. Frontiers in immunology 2024 8 15 1386427. Ziqiang Wang, Jing Zhang, Chao Zuo, Huili Chen, Luyao Wang, Yiluo Xie, Hongyu Ma, Shengping Min, Xiaojing Wang, Chaoqun Li |
The influence of nutritional status, lipid profile, leptin concentration and polymorphism of genes encoding leptin and neuropeptide Y on the effectiveness of immunotherapy in advanced NSCLC patients. BMC cancer 2024 8 24 (1): 937. Ma?gorzata Fr?k, Anna Grenda, Pawe? Krawczyk, Barbara Ku?nar-Kami?ska, Pawe? Pazdrowski, Karolina K?dra, Izabela Chmielewska, Janusz Milanows |
WFDC2 is a potential prognostic and immunotherapy biomarker in lung adenocarcinoma. The Journal of international medical research 2024 7 52 (7): 3000605241258893. Bo Min, Yan Wa |
Profound ctDNA and radiological responses after 2 cycles of avelumab in a metastatic Merkel cell carcinoma of the head and neck. Oral oncology 2024 7 157 106971. Santiago Cabezas-Camarero, Pedro Pérez-Segura, Alejandro Riquelme, Javier Román-Garc |
Generation of novel lipid metabolism-based signatures to predict prognosis and immunotherapy response for colorectal adenocarcinoma. Scientific reports 2024 7 14 (1): 17158. Yi Wang, Jun Yao, Zhe Zhang, Luxin Wei, Sheng Wa |
Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma. Journal of the National Cancer Center 2024 7 3 (3): 236-249. Aihetaimujiang Anwaier, Wenhao Xu, Wangrui Liu, Shiyin Wei, Xi Tian, Yuanyuan Qu, Jianfeng Yang, Hailiang Zhang, Dingwei |
Construction and validation of a TTN mutation associated immune prognostic model for evaluating immune microenvironment and outcomes of gastric cancer: An observational study. Medicine 2024 7 103 (29): e38979. Ruyue Chen, Zengwu Yao, Lixin Jia |
Somatic CpG hypermutation is associated with mismatch repair deficiency in cancer. Molecular systems biology 2024 7 . Aidan Flynn, Sebastian M Waszak, Joachim Weischenfel |
Immunomodulatory gene polymorphisms in non-small cell lung carcinoma susceptibility and survival. Heliyon 2024 7 10 (12): e33003. Vithiya Dewarajan, Nourhan Elsayed, Jhi Biau Foo, Yin Sim Tor, Sze Shin Low, Wai Siong Ch |
Blood Tumor Mutational Burden Alone Is Not a Good Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Gastrointestinal Tumors. Journal of immunotherapy (Hagerstown, Md. : 1997) 2024 7 . James Yu, Robin Park, Ruoyu Miao, Iman Imanirad, Moazzam Shahzad, Jose M Laborde, Todd C Knepper, Christine M Walko, Richard K |
Accelerated clinical response achieved by combining short-term tumor-directed photodynamic therapy with immunotherapy-based systemic therapies in synchronous colorectal cancer with MSI-H and POLE mutation: a case report. Frontiers in immunology 2024 7 15 1402334. Yuhan Wang, Lei Gao, Bin Ma, Jianming Shi, Zhenyu Yin, Weidong Zhu, Hao Ch |
Primary Tumor Characteristics as Biomarkers of Immunotherapy Response in Advanced Melanoma: A Retrospective Cohort Study. Cancers 2024 7 16 (13): . Rachel S Goodman, Seungyeon Jung, Kylie Fletcher, Hannah Burnette, Ismail Mohyuddin, Rebecca Irlmeier, Fei Ye, Douglas B Johns |
- Page last reviewed:Feb 1, 2024
- Content source: